[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing and Abstracting::
Editorial Policies::
For Authors::
For Reviewers::
Registration::
Contact us::
Publication Ethics::
Ethical Policies::
Data Sharing Policy::
Peer Review Process::
Articles in Press::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 4, Issue 2 (10-2026) ::
injbir 2026, 4(2): 109-125 Back to browse issues page
Challenges and opportunities in developing vaccines for the prevention of acute hepatopancreatic necrosis disease in shrimp
M. Gozari * , M. Sheikh Asadi , M. Gozari , A. Zaheri , S. Pourmozaffar , S. Tamadoni Jahromi , R. Azm , S. Behzady
Persian Gulf and Oman Sea Ecology Research Center
Abstract:   (8 Views)
Acute hepatopancreatic necrosis disease (AHPND) is one of the most devastating bacterial diseases affecting shrimp aquaculture, causing severe economic losses worldwide. Traditionally, shrimp have been considered incapable of developing adaptive immune responses because they lack the classical antibody-mediated immune system found in vertebrates. However, accumulating evidence suggests that shrimp and other invertebrates possess forms of immune priming and specific innate immunity that can provide enhanced protection against repeated pathogen exposure. These findings have renewed interest in the development of vaccine-like strategies for disease prevention in shrimp farming. The increasing global restrictions on antibiotic use in aquaculture have further accelerated research into immunostimulants, oral vaccines, recombinant antigens, nucleic acid-based approaches, and other innovative prophylactic strategies against bacterial pathogens, including the causative agents of AHPND. Nevertheless, significant biological and technical challenges remain, including the limited understanding of immune memory mechanisms, antigen delivery systems, immune response durability, and large-scale field application. This review summarizes current knowledge of shrimp immune mechanisms relevant to AHPND prevention, critically evaluates existing vaccine development strategies and experimental evidence, discusses the role of immune-related molecules such as Dscam and innate immune priming, and highlights the major challenges and future opportunities for developing effective and commercially viable vaccination approaches for sustainable shrimp aquaculture.
Keywords: Acute hepatopancreatic necrosis disease (AHPND), Shrimp immunity, Innate immune memory, Immune priming, Dscam, Vibrio parahaemolyticus, Shrimp vaccine, Sustainable aquaculture
Full-Text [PDF 398 kb]   (1 Downloads)    
Type of Study: Research | Subject: Special
Received: 2026/06/11 | Accepted: 2026/10/2 | Published: 2026/10/2
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gozari M, Sheikh Asadi M, Gozari M, Zaheri A, Pourmozaffar S, Tamadoni Jahromi S, et al . Challenges and opportunities in developing vaccines for the prevention of acute hepatopancreatic necrosis disease in shrimp. injbir 2026; 4 (2) :109-125
URL: http://injbir.com/article-1-86-en.html


Volume 4, Issue 2 (10-2026) Back to browse issues page
International Journal of Biological Reports International Journal of Biological Reports
Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4745